| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| IMPEL PHARMACEUTICALS INC | Chief Commercial Officer | Stock Option (right to buy) | 50,000 | 14 Feb 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000120919123010248-paolillo-leonard-2023-02-14 | IMPEL PHARMACEUTICALS INC | 14 Feb 2023 | 1 | $0 | 4 | Chief Commercial Officer | 16 Feb 2023, 17:23 |
| /report/000120919122005451-paolillo-leonard-2022-01-26 | IMPEL NEUROPHARMA INC | 26 Jan 2022 | 1 | $0 | 4 | Chief Commercial Officer | 28 Jan 2022, 16:05 |
| /report/000120919121048220-paolillo-leonard-2021-07-20 | IMPEL NEUROPHARMA INC | 20 Jul 2021 | 1 | $0 | 4 | Chief Commercial Officer | 26 Jul 2021, 18:02 |